WWB declines, for the 14th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
API sourcing
Page 13 of 23 of this archive, newest first.
What a 15% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
What a 13% rise in coupling-reagent prices does to a 10 mg vial
Follow the resin, not the catalogue.
Zhuhai export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Xi'an export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
SGN declines, for the 23rd time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at BCH in February, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 31% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.
Who signed this, and what did they undertake by signing it
Two signatures — one who performed the work, one who approved its release — are the ordinary regulated convention and are almost unknown here.
What changed at CPC in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Zhuhai export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
WXT declines, for the 19th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What changed at SGN in January, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
TFC declines, for the 16th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The certificate says 2025. The vial in your hand does not say anything.
What happens to traceability when bulk material is subdivided, repackaged and relabelled two or three times before sale.
What a 32% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
What a 41% rise in coupling-reagent prices does to a 5 mg vial
Follow the resin, not the catalogue.
ERP declines, for the 3rd time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What a 32% rise in coupling-reagent prices does to a 30 mg vial
Follow the resin, not the catalogue.
TFC declines, for the 15th time, to name its synthesis house
Documentation practice is the only part of vendor quality a buyer can assess before purchase.